The results of a new study suggest that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA.
Click here for original story, Immunotherapy drug found safe in treating cancer patients with HIV, study suggests
Source: ScienceDaily